EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
RPRX
Royalty Pharma is the world's largest buyer of biopharmaceutical royalties and a leading funder of innovation in life sciences, operating at the intersection of science, medicine, and investing.
Eisai Licenses Nuvation Lung Cancer Pill; Alnylam's Stock Dips After Sales Data Report
Kailera Therapeutics Secures $600M Series B Funding Led by Bain Capital Private Equity
Zymeworks Secures $250M Royalty‑Backed Note From Royalty Pharma